However, NKG2A+ NK cells, and fresh NK cells, irrespective of the presence of KIR2DS4 alleles and missing ligands for iKIRs, did not react towards HLA-E+/HLA-G+ primary GBM cells (Figure 6b). The gene discussed is KLRC1; the disease is glioblastoma.